Navigation Links
CareFusion Names Edward Borkowski as Chief Financial Officer

SAN DIEGO, May 13 /PRNewswire-FirstCall/ -- CareFusion Corporation, the company that will become public from the planned spinoff of Cardinal Health's clinical and medical products businesses, today announced that Edward J. Borkowski has been named chief financial officer (CFO).

Borkowski, 49, has been CFO of Mylan, Inc. since 2002 where he helped transform the company from a U.S.-based generic business to one of the largest generic pharmaceutical companies in the world, operating in more than 60 countries. During his tenure at Mylan, the company grew revenue from $900 million to more than $4.5 billion through the combination of organic growth and acquisition, including a $7 billion acquisition of Merck Generics in 2007. Borkowski also played a key role in Mylan's acquisition of Matrix Laboratories in 2006, the largest acquisition in India's pharmaceutical sector at the time. He will start with CareFusion on May 26.

"Ed has a proven record of identifying growth opportunities and executing against them with very positive results for shareholders," said David Schlotterbeck, chief executive officer of CareFusion. "He will be a key contributor to our management team as we execute our strategies for growth."

Prior to Mylan, Borkowski was vice president of global finance and information technology of consumer health care at Pharmacia Corporation. Through his various leadership positions with Mylan, Pharmacia and American Home Products Corporation, Borkowski has gained broad knowledge of the health care industry, with deep experience in corporate finance, treasury, tax, business development, information technology and operations. He earned his Bachelor of Science degree in economics and political science from Allegheny College and holds an MBA from Rutgers University.

Cardinal Health's target is to complete the planned spinoff later this summer. Completion and specific timing of the planned spinoff will depend on a number of factors, including the Form 10 being declared effective by the SEC and the Cardinal Health board of directors declaring a dividend of CareFusion stock to Cardinal Health shareholders. Other conditions to completing the planned spinoff include receipt of a ruling from the Internal Revenue Service that the spinoff will qualify as a tax-free transaction, CareFusion securing the necessary debt financing and both companies' debt being rated as investment grade. The satisfaction of some conditions will depend in part on credit market conditions at the time of the required financial transactions. No assurance can be provided as to the timing of the planned spinoff or that all conditions to the planned spinoff will be met.

About CareFusion Corporation

CareFusion Corporation is currently a wholly owned subsidiary of Cardinal Health (NYSE: CAH) and is expected to become a public company from the planned spinoff of Cardinal Health's clinical and medical products businesses. The global company is expected to have annual revenues approaching $4 billion(1) and will serve the health care industry with products and services that help hospitals improve the safety and quality of health care. With a focus on breaking the cycle of harmful medication errors and reducing hospital-acquired infections, CareFusion develops market-leading technologies including Alaris(R) IV pumps, Pyxis(R) automated dispensing and patient identification systems, MedMined(TM) electronic infection surveillance service, AVEA and Pulmonetic Systems ventilation and respiratory products, Jaeger and SensorMedics pulmonary products, ChloraPrep(R) infection prevention products and V. Mueller(R) surgical instruments. CareFusion employs more than 15,000 people across its global operations. The company intends to apply to have its shares of common stock listed on the New York Stock Exchange under the ticker symbol "CFN."

(1) The estimate of the pro forma revenue for the clinical and medical products company that is expected to be spun off is an estimate of the revenue for CareFusion for the 12 months ending June 30, 2009 in accordance with generally accepted accounting principles and includes adjustments expected to reflect CareFusion as a stand-alone entity. This estimate is based on Cardinal Health's previously announced revenue expectations for fiscal 2009 and on assumptions that management currently believes are reasonable, but actual revenue for CareFusion may vary materially from this estimate.

Cautions Concerning Forward-Looking Statements

This news release contains forward-looking statements addressing the planned spinoff of Cardinal Health's clinical and medical products businesses as a separate company named CareFusion, the divestiture by Cardinal Health of any retained shares of CareFusion, and the expected financial results of CareFusion after giving effect to the spinoff, each of which is dependent upon future events or developments. These matters are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. These risks and uncertainties include uncertainties regarding the planned spinoff of CareFusion, including the timing and terms of any such spinoff and whether such spinoff will be completed as it is subject to a number of conditions, the timing of the divestiture of any shares of CareFusion retained by Cardinal Health and uncertainties regarding the impact on CareFusion and the market for its securities if the spinoff is accomplished. In addition, Cardinal Health and CareFusion are subject to additional risks and uncertainties described in CareFusion's Form 10 and Cardinal Health's Form 10-K, Form 10-Q and Form 8-K reports (including all amendments to those reports) and exhibits to those reports. Except to the extent required by applicable law, Cardinal Health and CareFusion undertake no obligation to update or revise any forward-looking statement.

SOURCE CareFusion Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. CareFusion Corporation Files Form 10 Registration Statement
2. AMA Foundation Names Minority Scholars Award Recipients
3. The Ensign Group Announces the Retirement of CFO Alan J. Norman; Names Suzanne D. Snapper as New Chief Financial Officer
4. iCRco Names Mark Valentine President and COO
5. OTC Perspectives Magazine Names The Top OTC/Healthcare Marketers of the Year
6. Prematics Names S. Michael Ross Chief Medical Officer and Senior Vice President of Business Development
7. Casenet Names Bill Wisotzkey Vice President of Product Management and Design
8. Fad Baby Names Tend to Fizzle Fast
9. Case in Point Magazine Names URAC Senior Vice President Leader in Health Care Accreditation
10. American Psychiatric Foundation Names 2009 Recipients of Awards for Advancing Minority Mental Health
11. REES Names Director of Sustainability
Post Your Comments:
(Date:11/27/2015)... ... , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of ... than 3.7 billion people under the age of 50 – or 67% of the population ... global estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle ...
(Date:11/27/2015)... DE (PRWEB) , ... November 27, 2015 , ... ... member of the well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s ... an independent group of Microsoft Dynamics SL software users, partners, industry experts and ...
(Date:11/27/2015)... MINNEAPOLIS, Minn. (PRWEB) , ... November 27, 2015 ... ... you start failing. Secura Consultants has prided itself for not only fulfilling the ... best income protection solutions at an affordable price and providing top-tier customer service. ...
(Date:11/27/2015)... ... ... CBD College is proud to announce that on November 20th, ... its Diagnostic Medical Sonography program. CBD College is honored to join this very short ... universities in the state of California make the cut. CBD College is officially the ...
(Date:11/27/2015)... ... November 27, 2015 , ... Dr. Thomas Dunlap ... and Dr. Tucker Bierbaum with Emergency Medicine at St., Joseph Health System’s ... STEMI and Sepsis conditions present in similar ways and require time-critical intervention to avoid ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... announced the addition of the  "2016 ... the Global Cell Surface Testing Market: ... report to their offering.  --> ... addition of the  "2016 Future Horizons ...
(Date:11/26/2015)... , Nov. 26, 2015 Research and ... the "Advanced Wound Care Market by Type (Dressings, ... End User (In-Patient Facility, Out-Patient Facility), and Geography - ... --> --> ... description, definition and forecast of the global advanced wound ...
(Date:11/26/2015)... , November 26, 2015 ... the "Self Administration of High Viscosity Drugs" ... ) has announced the addition of the ... report to their offering. --> Research ... addition of the "Self Administration of High ...
Breaking Medicine Technology: